Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: Results of a survey of 985 patients

Clinical Therapeutics

Volumn 30, Issue 8, 2008, Pages 1540-1552

  Berti, Dana ^a   Moons, Philip ^a,b   Dobbels, Fabienne ^a   Deuson, Robert ^c   Janssens, Ann ^b   De Geest, Sabina ^a,d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c AMGEN INC   (United States)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

adverse effects; corticosteroids; immune thrombocytopenic purpura; patient reported outcomes; symptom experience

Indexed keywords

CORTICOSTEROID;

ADULT; ANXIETY; ARTICLE; BACKACHE; BRITTLE SKIN; BUFFALO HUMP; CORTICOSTEROID THERAPY; DEPRESSION; DISEASE SURVEILLANCE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; DRY SKIN; EMOTIONAL STRESS; FACIES; FATIGUE; FEMALE; GYNECOMASTIA; HAND TREMOR; HEART PALPITATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LIBIDO DISORDER; LIP SORE; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; MENTAL INSTABILITY; MOUTH ULCER; MUSCLE WEAKNESS; NAIL DISEASE; NAUSEA; NIGHTMARE; OILY SKIN; OVERNUTRITION; PATIENT SATISFACTION; PUFFY FACE; QUALITY OF LIFE; RASH; RATING SCALE; RESTLESSNESS; SIDE EFFECT; SKIN BRUISING; SKIN MANIFESTATION; SLEEP DISORDER; SPINE MALFORMATION; STOMACH DISCOMFORT; SWEATING; SYMPTOM CHECKLIST 90; SYMPTOM DISTRESS SCALE; THIRST; THORAX PAIN; VISUAL DISORDER;

ADULT; DATA COLLECTION; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERNET; MALE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 51549101811     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.08.005     Document Type: Article

References (28)

1. Burden of Illness of Idiopathic Thrombocytopenic Purpura (ITP)-An Overview (2004), Cerner Health Insights, Beverly Hills, Calif
2. Bussel J., and Tarantino M. Review of therapies for immune thrombocytopenic purpura. Semin Hematol. 43 Suppl 5 (2006) S1-S2
3. Cines D.B., and Blanchette V.S. Immune thrombocytopenic purpura. N Engl J Med. 346 (2002) 995-1008
4. Cohen Y.C., Djulbegovic B., Shamai-Lubovitz O., and Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistent low platelet counts. Arch Intern Med. 160 (2000) 1630-1638
5. Fries Jr. A.F. Survey of non-traditional treatments of ITP: Preliminary results. Platelet News. 4 (2002) 1-3
6. Gadenstätter M., Lamprecht B., Klingler A., et al. Splenectomy versus medical treatment for idiopathic thrombocytopenic purpura. Am J Surg. 184 (2002) 606-610
7. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet. 349 (1997) 1531-1536
8. McMillan R. The pathogenesis of chronic immune (idiopathic) thrombocytopenic purpura. Semin Hematol. 37 Suppl 1 (2000) 5-9
9. George J.N., Woolf S.H., Raskob G.E., et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood. 88 (1996) 3-40
10. Bussel J. Treatment of immune thrombocytopenic purpura in adults. Semin Hematol. 43 Suppl 5 (2006) S3-S10
11. McMillan R. Therapy for adults with refractory chronic immune thrombocytopenic purpura. Ann Intern Med. 126 (1997) 307-314
12. Rodeghiero F. Idiopathic thrombocytopenic purpura: An old disease revisited in the era of evidence-based medicine. Haematologica. 88 (2003) 1081-1087
13. Bromberg M.E. Immune thrombocytopenic purpura-the changing therapeutic landscape. N Engl J Med. 355 (2006) 1643-1645
14. George J.N., and Vesely S.K. Immune thrombocytopenic purpura-let the treatment fit the patient. N Engl J Med. 349 (2003) 903-905
15. Moons P., Vanrenterghem Y., van Hooff J.P., et al. Steroids may compromise quality of life of renal transplant recipients on a tacrolimus-based regimen. Transplant Proc. 34 (2002) 1691-1692
16. US Food and Drug Administration. Guidance for industry. Patient-reported outcome measures: Use in medical product development to support labeling claims. http://www.fda.gov/cber/gdlns/prolbl.htm Accessed July 11, 2008
17. Acquadro C., Berzon R., Dubois D., et al. Incorporating the patient's perspective into drug development and communication: An ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health. 6 (2003) 522-531
18. Rhodes V.A., and Watson P.M. Symptom distress-the concept: Past and present. Semin Oncol Nurs. 3 (1987) 242-247
19. Leventhal H., and Johnson J.E. Laboratory and field experimentation: Development of a theory of self-regulation. In: Wooldridge P.J., Schmitt M.H., Skipper J.K., and Leonard R.C. (Eds). Behavioral Science and Nursing Theory (1983), Mosby, St. Louis, Mo 189-262
20. Mathias S.D., Bussel J.B., George J.N., et al. A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: Psychometric testing in an open-label clinical trial. Clin Ther. 29 (2007) 950-962
21. Dobbels F, Moons P, Abraham I, et al. Measuring symptom experience of side-effects of immunosuppressive drugs: The Modified Transplant Symptom Occurrence and Distress Scale [published online ahead of print April 23, 2008]. Transpl Int.
22. Bross I. How to use ridit analysis. Biometrics. 14 (1958) 18-38
23. Sermeus W., and Delesie L. Ridit analysis on ordinal data. West J Nurs Res. 18 (1996) 351-359
24. Benjamini Y., and Hochbert Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc B. 57 (1995) 289-300
25. De Geest S., and Moons P. The patient's appraisal of side-effects: The blind spot in quality-of-life assessments in transplant recipients. Nephrol Dial Transplant. 15 (2000) 457-459
26. Baid S.K., and Nieman L.K. Therapeutic doses of glucocorticoids: Implications for oral medicine. Oral Dis. 12 (2006) 436-442
27. Min D.I., and Monaca A.P. Complications associated with immunosuppressive therapy and their management. Pharmacotherapy. 11 (1991) 119S-125S
28. Thomas T.P. The complications of systemic corticosteroid therapy in the elderly. A retrospective study. Gerontology. 30 (1984) 60-65